Skip to main content

Table 3 Demographic datas and clinical characteristics of subjects in the study

From: Differential gene expression of ABCG2, SLC22A12, IL-1β, and ALPK1 in peripheral blood leukocytes of primary gout patients with hyperuricemia and their comorbidities: a case–control study

  

Controls

N = 52

 

Patients

N = 36

n

 

n

 

SERUM

 Uric Acid (mg/dL)

52

5.57 ± 0.17

36

7.88 ± 0.34*

 Glucose (mg/dL)

52

86.96 ± 1.24

36

88.76 ± 2.99

 Cholesterol (mg/dL)

52

193.04 ± 5.29

35

188.27 ± 7.08

 Triglycerides (mg/dL)

52

141.73 ± 13.89

35

244.45 ± 28.92*

 Creatinine (mg/DL)

52

0.95 ± 0.08

35

1.21 ± 0.18*

 HDL

(mg/dL)

50

50.86 ± 1.96

33

38.15 ± 1.69*

 LDL

(mg/dL)

50

115.50 ± 4.16

33

101.35 ± 33.00**

 CRP

(mg/L)

23

5.00 ± 2.7

26

5.98 ± 4.6

ORINE

 Uric Acid (mg/24 h)

NA

NA

7

881.61 ± 621

 Creatinine

Clearance (cc/min)

NA

NA

4

123.95 ± 50

  1. NA = does not apply.The values represent the mean ± SD. The p-values were estimated with Student’s T test and U Mann Whitney test. ** p < 0.001, * p < 0.01